Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Belong.Life operates the world’s largest social and professional networks for cancer patients (Belong – Beating Cancer Together) and multiple sclerosis patients (BelongMS), offering AI-driven mentors (such as Dave the Cancer Mentor, Sophie the MS Mentor, Tara for clinical trials, Fred for weight/health, and Elina for menopause), peer communities, and personalized support. The platform is used by over a million patients in 100+ countries and delivers evidence-based, 24/7 guidance, clinical trial matching, and real-world data for research. Belong’s AI technology is also licensed as SaaS for partners in women’s health and other therapeutic areas. The company's platforms serve over a million patients globally, supporting education, peer connection, and clinical research.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Belong.Life.